A study matters in context. We look at who and what was studied, the daily amount, the outcome, the duration, and the limitation that belongs beside the finding.
One clear research boundary.
The research discussed here was conducted on individual ingredients. Skin Hydration Shield is made with clinically studied ingredients at evidence-backed doses, and each ingredient keeps the benefit territory its evidence supports.
"Clinically studied." Lovely. We have follow-up questions.
Was the study randomized? Blinded? Placebo-controlled? Did it use the same ingredient and daily amount found in this bottle? What material did the researchers test? What did they actually measure?
Then comes the inconvenient part. A small sample, a materially different test ingredient, an open-label arm, or a missing placebo belongs beside the finding it qualifies.
White coats from stock-photo websites were not invited.
CeraLOK® Rice Ceramide Powder — 40 mg per daily serving
CeraLOK helps support the skin's moisture barrier and reduce moisture loss.
This is a particularly clean study match. CeraLOK is the U.S. name for ORYZA Ceramide type PCD. A randomized, double-blind, placebo-controlled study of 44 adults used the same branded ingredient at the same 40 mg daily amount for twelve weeks.[1]
Researchers measured reduced cheek moisture loss after four and twelve weeks. Lip moisture improved at twelve weeks.
Two reconstructed-human-epidermis studies examined how rice glucosylceramides, elasticamide, and beta-sitosterol glucoside can affect transepidermal water loss, epidermal structure, and ceramide production.[2][3] Those studies help explain a plausible mechanism. The product-exact human trial carries the consumer benefit claim.
What this supports:
- CeraLOK rice ceramides help support the skin's moisture barrier.
- CeraLOK helps reduce moisture loss from facial skin.
- CeraLOK supports hydrated skin from within.
120 mg of hyaluronic acid per daily serving
Hyaluronic acid helps support hydration, elasticity, and the appearance of fine lines.
Skin Hydration Shield contains 120 mg of hyaluronic acid. That exact daily amount appears in several randomized, double-blind, placebo-controlled trials. Across the evidence, researchers reported benefits for hydration, moisture retention, wrinkle appearance, firmness, and elasticity.
In one 120 mg trial, both studied hyaluronic-acid groups improved dry-skin conditions.[4]
Another 120 mg trial reported a significant reduction in crow's-feet wrinkle volume after eight weeks.[5]
A separate 120 mg trial reported higher facial skin water content, lower facial water loss, improved wrinkle assessments, and improved firmness-related measurements at twelve weeks.[6]
A randomized, double-blind, placebo-controlled trial of 150 adults also reported improvements in facial hydration, moisture loss, periorbital wrinkle depth, and several elasticity or firmness measurements at 120 mg daily.[7]
Different studies measured different endpoints. Together, they give the formula's 120 mg daily amount a strong human-evidence base for the skin claims Roral makes.
What this supports:
- Hyaluronic acid helps support skin hydration and moisture.
- Hyaluronic acid helps support skin barrier function by helping reduce transepidermal water loss.
- Hyaluronic acid helps reduce the appearance of fine lines and wrinkles.
- Hyaluronic acid helps support skin elasticity.
1,000 mg per daily serving
MSM helps support hydration, smoother texture, firmness, and elasticity.
The published MSM study had two parts. Its randomized, placebo-controlled portion used 3,000 mg daily. A separate dose-response portion compared 1,000 mg and 3,000 mg daily without a placebo group.[8]
The 1,000 mg amount in Skin Hydration Shield matches the lower dose-response amount. Researchers reported changes in visually graded wrinkles and skin texture, plus instrumental measures of hydration, firmness, and elasticity. The lower dose appeared slower on hydration, with measurements continuing through twelve weeks. Some visually graded outcomes were measured through sixteen weeks.
What this supports:
- MSM helps reduce the appearance of fine lines and wrinkles.
- MSM helps support smoother skin texture.
- MSM helps support skin hydration, firmness, and elasticity.
Evidence with more restraint:
The study also reported changes in visual grading of radiance. That outcome has less support than hydration or texture.
120 mg per daily serving
Vitamin C supports normal collagen formation for the normal function of skin.
Vitamin C is a cofactor in normal collagen formation. It also helps protect cells from oxidative stress. Skin Hydration Shield provides 120 mg per daily serving.[9][10]
An analysis of 4,025 women ages 40 to 74 found that higher dietary vitamin C intake was associated with a lower likelihood of a wrinkled appearance and dry skin.[11] This is a cross-sectional association — an observed correlation in diet, not a trial result.
What this supports:
- Vitamin C supports your skin's normal collagen formation.
- Vitamin C helps protect cells from oxidative stress.
Study measurement points, not appointments for your skin
The timeline stays, and so does its meaning.
Different ingredient studies measured different outcomes on different calendars. Your experience may not follow any of them.
Think in weeks. Give the routine a fair try. Skin keeps her own calendar.
One row per study, limitations included
The studies, side by side.
Each row is one human study: the material tested, the daily amount, who was studied, what was measured, what was reported, and the limitation that belongs beside it. Every study here tested an individual ingredient. None of them tested the finished Skin Hydration Shield formula.
| Ingredient | Material vs. our formula | Daily amount | Participants | Design | Length | What was measured | Reported result | Limitations | Source |
|---|---|---|---|---|---|---|---|---|---|
| CeraLOK® rice ceramides | Same. The study used the same branded extract (Oryza Ceramide®, type PCD) at the same daily amount as the formula. | 40 mg/day (formula: 40 mg) | 44 adults | Randomized, double-blind, placebo-controlled | 12 weeks | Cheek moisture loss (TEWL); lip moisture | Cheek moisture loss was reduced after 4 and 12 weeks. Lip moisture improved at 12 weeks. | Supplier-affiliated authors. Endpoints cover facial moisture only. Fine-line and firmness claims belong to hyaluronic acid and MSM. | Takara et al. (2021) |
| Hyaluronic acid | Comparable. The study used standard oral hyaluronans at the formula's daily amount, in separate 300 kDa and 800 kDa arms. | 120 mg/day (formula: 120 mg) | 61 women | Randomized, double-blind, placebo-controlled | 6 weeks, plus a measurement 2 weeks after intake ended | Stratum-corneum moisture; dry-skin condition | Both hyaluronan groups improved dry-skin condition. The clearest between-group moisture result was in the 300 kDa group two weeks after intake ended. | Ingredient-maker-affiliated authors. The key moisture difference appeared after intake ended. | Kawada et al. (2015) |
| Hyaluronic acid | Comparable. The study used hyaluronan at the formula's daily amount, in separate 2 kDa and 300 kDa arms. | 120 mg/day (formula: 120 mg) | 60 adults | Randomized, double-blind, placebo-controlled | 12 weeks | Crow's-feet wrinkle measures (image analysis of skin replicas) | The 300 kDa group significantly reduced the change in wrinkle-volume ratio versus placebo at week 8 (p=0.046). | The 2 kDa arm narrowly missed significance (p=0.052), so it is not a separate significant replication. Ingredient-maker-affiliated authors. | Oe et al. (2017) |
| Hyaluronic acid | Comparable. The study used oral hyaluronan (Hyabest® (S) LF-P) at the formula's daily amount. The paper does not report the material's molecular weight. | 120 mg/day (formula: 120 mg) | 40 adults | Randomized, double-blind, placebo-controlled | 12 weeks | Facial hydration; facial moisture loss (TEWL); wrinkle assessment; firmness indices | Higher facial water content, lower facial moisture loss, and improved wrinkle and firmness measurements versus placebo at 12 weeks. | Small study (40 participants). Ingredient-maker-affiliated authors. The test material's molecular weight is not documented. | Hsu et al. (2021) |
| Hyaluronic acid | Comparable. The study used sodium hyaluronate (1.8 MDa), with one arm at the formula's daily amount. | 60 or 120 mg/day (formula: 120 mg) | 150 adults | Randomized, double-blind, placebo-controlled | 12 weeks | Facial hydration; moisture loss (TEWL); periorbital wrinkle depth; elasticity and firmness | At 120 mg: improved facial hydration, reduced moisture loss, reduced periorbital wrinkle depth, and several improved elasticity or firmness measurements versus placebo. | Funded and conducted by the ingredient manufacturer. Many secondary outcomes were tested without a multiplicity correction. | Dolečková et al. (2025) |
| Hyaluronic acid (context) | Different dose. The study used 300 kDa hyaluronic acid at 100 or 200 mg/day, not the formula's 120 mg. | 100 or 200 mg/day (formula: 120 mg) | 129 participants | Randomized, double-blind | Hydration reported after 2–8 weeks | Skin hydration | Oral hyaluronic acid significantly promoted skin hydration after 2 to 8 weeks in both young and elderly groups. | The studied doses bracket, but do not match, the formula's amount. Context for the hydration timeline only. | Gao et al. (2023) |
| MSM | Same ingredient. The placebo-controlled portion used 3,000 mg/day; the 1,000 mg/day arm matches the formula but had no placebo group. | 1,000 or 3,000 mg/day (formula: 1,000 mg) | 20 in the pilot trial; 63 in the dose-response study | Pilot randomized, placebo-controlled trial plus a dose-response study | Up to 16 weeks | Facial wrinkles; skin texture and roughness; hydration; firmness and elasticity | Reduced visually graded wrinkles and roughness, and improved hydration, firmness, and elasticity. The 1,000 mg dose was slower on hydration, improving through 12 weeks. | The 1,000 mg arm had no placebo group. MSM corroborates claims carried more strongly by the hyaluronic-acid studies. | Muizzuddin & Benjamin (2022) |
| Vitamin C | Different. The study observed dietary vitamin C intake, not a fixed supplement dose. | Dietary intake, no fixed dose (formula: 120 mg) | 4,025 women ages 40–74 | Cross-sectional analysis (NHANES I) | Single time point | Dermatologist-assessed wrinkled appearance and dryness | Higher dietary vitamin C intake was associated with a lower likelihood of a wrinkled appearance and dry skin. | Cross-sectional association only. It cannot show cause and effect. | Cosgrove et al. (2007) |
Where the line stays.
The evidence does not establish proven synergy, a clinical trial of the finished formula, or a personal results date. The studies above support specific ingredients, doses, and endpoints.
It does not make Skin Hydration Shield a replacement for moisturizer, sunscreen, medical care, or a balanced diet.
Fine print is where weak claims go to hide. The line is staying up here.
References
- Takara T, et al. (2021). "Oryza Ceramide®, a Rice-Derived Extract Consisting of Glucosylceramides and β-Sitosterol Glucoside, Improves Facial Skin Dehydration in Japanese Subjects." Functional Foods in Health and Disease, 11(8), 385–407. Randomized, double-blind, placebo-controlled trial, n=44.View study →
- Takeda S, et al. (2023). "Comparative Study on Epidermal Moisturizing Effects and Hydration Mechanisms of Rice-Derived Glucosylceramides and Ceramides." International Journal of Molecular Sciences, 24(1), 83. Reconstructed-human-epidermis model.View study →
- Takeda S, et al. (2021). "β-Sitosterol 3-O-D-Glucoside Increases Ceramide Levels in the Stratum Corneum via Up-Regulated Expression of Ceramide Synthase-3 and Glucosylceramide Synthase in a Reconstructed Human Epidermal Keratinization Model." PLOS ONE, 16(3), e0248150. Reconstructed-human-epidermis model.View study →
- Kawada C, et al. (2015). "Ingestion of Hyaluronans (Molecular Weights 800k and 300k) Improves Dry Skin Conditions." Journal of Clinical Biochemistry and Nutrition, 56(1), 66–73. Randomized, double-blind, placebo-controlled trial.View study →
- Oe M, et al. (2017). "Oral Hyaluronan Relieves Wrinkles: A Double-Blinded, Placebo-Controlled Study Over a 12-Week Period." Clinical, Cosmetic and Investigational Dermatology, 10, 267–273. Randomized, double-blind, placebo-controlled trial.View study →
- Hsu T-F, et al. (2021). "Oral Hyaluronan Relieves Wrinkles and Improves Dry Skin." Nutrients, 13(7), 2220. Randomized, double-blind, placebo-controlled trial, n=40.View study →
- Dolečková I, et al. (2025). "Oral Sodium Hyaluronate Improves Skin Hydration, Barrier Function and Signs of Aging: A Randomized, Double-Blind, Placebo-Controlled Trial in 150 Healthy Adults." Scientific Reports. doi:10.1038/s41598-025-32758-5. Randomized, double-blind, placebo-controlled trial, n=150; 1.8 MDa sodium hyaluronate.View study →
- Muizzuddin N and Benjamin R (2022). "Beauty from Within: Oral Administration of a Sulfur-Containing Supplement Methylsulfonylmethane Improves Signs of Skin Ageing." International Journal for Vitamin and Nutrition Research, 92(3–4), 182–191. Pilot randomized trial and dose-response study.View study →
- Pullar JM, Carr AC, and Vissers MCM (2017). "The Roles of Vitamin C in Skin Health." Nutrients, 9(8), 866. Review.View study →
- European Commission (2012). Commission Regulation (EU) No 432/2012. Official Journal of the European Union, L136, 1–40. Authorized vitamin C health claims.View study →
- Cosgrove MC, et al. (2007). "Dietary Nutrient Intakes and Skin-Aging Appearance Among Middle-Aged American Women." American Journal of Clinical Nutrition, 86(4), 1225–1231. Cross-sectional analysis, n=4,025.View study →
- Gao Y, et al. (2023). "Oral Administration of Hyaluronic Acid to Improve Skin Conditions via a Randomized Double-Blind Clinical Test." Skin Research and Technology, 29, e13531. Randomized, double-blind trial, n=129; 100 or 200 mg/day of 300 kDa hyaluronic acid.View study →
Coming soon
The bottle is not ready for breakfast yet.
Skin Hydration Shield is coming soon. Join the waitlist and we will email you when ordering opens.
You are on the list.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.